Dongfureng Secures Freeze Dryer Maintenance Contract from Jiangzhong Pharmaceutical

A high-value freeze dryer maintenance contract has been awarded to Dongfureng Technology Group Co., Ltd. by Jiangzhong Pharmaceutical Co., Ltd., one of China‘s leading traditional Chinese medicine manufacturers.

The procurement results announcement, published on June 1, 2026, confirmed that Jiangzhong Pharmaceutical completed the review process for its biochemical workshop freeze dryer maintenance services project.

The project was procured through a single-source direct procurement method, and Dongfureng Technology Group Co., Ltd. was named as the winning supplier.

The procurement documents were released by Jiangzhong Pharmaceutical, which is headquartered in Nanchang, Jiangxi Province.

Dongfureng Technology Group Co., Ltd. is a Shanghai-headquartered manufacturer specializing in pharmaceutical freeze dryers and integrated aseptic processing systems.

The company has established itself as a leading domestic supplier of lyophilization equipment for the Chinese pharmaceutical industry.

The contract covers maintenance services for freeze dryers operating in Jiangzhong‘s biochemical workshop, ensuring continuous production and compliance with pharmaceutical quality standards.

This sourcing decision reflects a broader trend in China‘s pharmaceutical freeze dryer market, where domestic equipment manufacturers are increasingly securing after-sales service and maintenance contracts from major drug makers.

As China’s freeze dryer market continues to expand—the global lyophilization equipment market was valued at $8.13 billion in 2025 and is projected to grow to $8.97 billion in 2026 at a CAGR of 10.2 percent—long-term service agreements represent a growing revenue stream for equipment manufacturers, extending their customer relationships well beyond the initial sale.